ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,263, issued on Aug. 5, was assigned to Navitor Pharmaceuticals Inc. (Boston).

"Modulators of sestrin-GATOR2 interaction and uses thereof" was invented by Kristina Michelle Fetalvero (Boston), Sridhar Narayan (Belmont, Mass.), David John O'Neill (Arlington, Mass.), Eddine Saiah (Brookline, Mass.) and Shomit Sengupta (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds, compositions thereof, and methods of using the same."

The patent was filed on March 25, 2022, under Application No. 17/704,892.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacg...